Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,585,300 | 2,878,800 | 1,201,000 | 2,243,000 | 2,144,000 |
| Marketable Securities | 6,052,300 | 4,211,100 | 2,972,000 | 2,728,200 | 1,142,600 |
| Receivables | 2,927,300 | 3,627,700 | 4,023,600 | 5,423,400 | 5,215,400 |
| Inventories | 1,658,100 | 1,898,700 | 2,554,700 | 2,964,300 | 3,579,300 |
| TOTAL | $21,049,300 | $13,475,200 | $11,527,200 | $14,386,400 | $12,961,600 |
| Non-Current Assets | |||||
| PPE Net | 14,398,200 | 14,713,700 | 14,169,000 | 14,195,600 | 13,103,400 |
| Investments And Advances | 1,107,900 | 6,727,100 | 7,941,200 | 7,255,100 | 6,983,500 |
| Intangibles | 1,604,400 | 1,764,900 | 1,949,400 | 7,241,000 | 7,491,000 |
| Other Non-Current Assets | 6,686,000 | 5,891,900 | 5,000,700 | 4,483,100 | 3,481,700 |
| TOTAL | $23,796,500 | $29,097,600 | $29,060,300 | $33,174,800 | $31,059,600 |
| Total Assets | $44,845,800 | $42,572,800 | $40,587,500 | $47,561,200 | $44,021,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 471,100 | 421,400 | 735,200 | 2,413,300 | 1,895,200 |
| Accrued Expenses | 5,277,800 | 5,288,100 | 3,772,800 | 3,365,600 | 3,213,200 |
| TOTAL | $13,242,400 | $11,744,100 | $9,569,600 | $12,375,200 | $11,544,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,125,600 | 4,691,500 | 5,096,000 | 4,879,000 | 4,798,600 |
| Other Non-Current Liabilities | 2,407,200 | 2,406,900 | 3,915,200 | 4,928,300 | 4,837,500 |
| TOTAL | $13,625,700 | $13,540,500 | $15,441,500 | $16,985,500 | $16,426,900 |
| Total Liabilities | $26,868,100 | $25,284,600 | $25,011,100 | $29,360,700 | $27,971,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,187,042 | 2,208,052 | 2,224,326 | 2,244,505 | 2,271,095 |
| Common Shares | 29,800 | 29,800 | 29,800 | 29,800 | 29,800 |
| Retained earnings | 37,980,000 | 36,626,300 | 34,142,000 | 35,434,900 | 31,489,600 |
| Other shareholders' equity | 51,900 | -45,700 | 66,000 | -98,900 | 10,500 |
| TOTAL | $17,977,700 | $17,288,200 | $15,576,400 | $18,200,500 | $16,050,100 |
| Total Liabilities And Equity | $44,845,800 | $42,572,800 | $40,587,500 | $47,561,200 | $44,021,200 |